Featured Events:

ChinaBio® Partnering Forum 2021
May 10–14, 2021
ChinaBio® Partnering Forum, in its new hybrid delivery, enables you to identify, meet and network with leaders across the life science value chain to accelerate your cross-border partnerships and expand your reach into the China market.

Written by Richard Daverman, PhD, Executive Editor, Greg B. Scott.


Click a link below to view the mailing archive as if it had been sent to you.

2021-01-24 01:30Week in Review: Suzhou's Adagene to Stage $125 Million IPO on NASDAQ
2021-01-23 01:30Sinovac to Expand Production of COVID-19 Vaccine to 2 Billion Doses
2021-01-22 01:30Adagene of Suzhou Files for $125 Million US IPO and more...
2021-01-21 01:30Immunotech of Beijing In-licenses Immunotherapy from T-Cure and more...
2021-01-20 01:30Sinovent Completes Pre-IPO Financing of at least $30 Million and more...
2021-01-19 01:30EdiGene Approved to Start China Trial of Gene-Edited Stem Cell Therapy and more...
2021-01-17 01:30Week in Review: BeiGene Signs $2.2 Billion Deal with Novartis for PD-1
2021-01-16 01:30EQRx Raises $500 Million to Develop China-Sourced Drugs for US Market and more...
2021-01-15 01:30ChinaBio® Report: 2020 China Life Science Investment Hits New Records and more...
2021-01-14 01:30Gracell to Start China Trial of Donor-derived CAR-T Therapy for B-ALL
2021-01-13 01:30BeiGene Out-Licenses Rights for PD-1 to Novartis in $2.2 Billion Deal and more...
2021-01-12 01:30ChinaBio at JP Morgan: China Biopharma Books Strong 2020, Despite Pandemic and more...
2021-01-10 01:30Week in Review: China Biopharma Starts 2021 with Over $1 Billion in Deals and IPOs
2021-01-09 01:30Gracell Raises $209 Million in US IPO for Novel CAR-T Therapies and more...
2021-01-08 01:30Zai Lab Acquires China Rights to Novel Autoimmune Drug in $175 Million Deal and more...
2021-01-07 01:30Keya Medical Completes $46 Million Round for AI-based Scanning Software and more...
2021-01-06 01:30Terns Completes $87 Million Financing to Advance Three NASH Candidates and more...
2021-01-05 01:30Shanghai Pharma to Build $1.8 Billion Novel Drug Facility in Zhangjiang Park and more...
2021-01-03 01:30Week in Review: DXY Raises $500 Million for Online Consumer Healthcare Site
2021-01-01 01:30ImmVira Completes C Round for Oncolytic Virus and Vector Candidates and more...

Please enter all required fields Click to hide
Correct invalid entries Click to hide

Subscribe >>

Not a ChinaBio®Today Subscriber?

Here's what you get with a paid subscription to ChinaBio® Today:
  • Website access to all current articles and commentary
  • Full access to over 2000 archived articles on the biotech industry

Greg B. Scott
Executive Editor
ChinaBio® Today

ChinaBio and ChinaBio Today are trademarks of ChinaBio LLC